James N Hughes1,2, Matthew Aubert1, Jessica Heatlie1, Alison Gardner3, Jozef Gecz2,3, Thomas Morgan4, Joseph Belsky5,6, Paul Q Thomas7,8. 1. School of Biological Sciences, University of Adelaide, Adelaide, SA, Australia. 2. Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia. 3. School of Pediatrics and Reproductive Health, The University of Adelaide, Adelaide, SA, Australia. 4. Novartis Institutes of Biomedical Research, Biomarkers Division, Cambridge, MA, USA. 5. Department of Medicine (Endocrinology), Yale University School of Medicine, New Haven, CT, USA. 6. Department of Medicine, Danbury Hospital, Danbury, CT, USA. 7. School of Biological Sciences, University of Adelaide, Adelaide, SA, Australia. paul.thomas@adelaide.edu.au. 8. Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia. paul.thomas@adelaide.edu.au.
Abstract
OBJECTIVES: IGSF1 deficiency syndrome (IDS) is a recently described X-linked congenital central hypothyroidism disorder characterized by loss-of-function mutations in the immunoglobulin superfamily member 1 (IGSF1) gene. The phenotypic spectrum and intrafamilial variability associated with IDS remain unclear due to a paucity of large, well-characterized pedigrees. Here, we present phenotypic analysis and molecular characterization of a five-generation pedigree with IGSF1 deficiency containing 10 affected males. PATIENTS AND METHODS: Pituitary function was assessed in all available family members (n = 8 affected males and n = 5 carrier females). Molecular characterization of the family was performed by Sanger sequencing of PCR products amplified from the IGSF1 locus and by array comparative genomic hybridization. RESULTS: A 42-kb IGSF1 deletion spanning the entire coding sequence was identified in all affected males. TSH deficiency, although subclinical in one case, was identified in all affected males (n = 8). PRL and GH deficiency were also present in 5 of 6 and 4 of 8 affected males, respectively. In contrast to previous reports, macroorchidism was not detected in any of the four affected males who were examined for this feature. Only 1 of 5 carrier females had pituitary dysfunction (TSH and GH deficiency). CONCLUSION: Individuals with identical IGSF1 deletions can exhibit variable pituitary hormone deficiencies, of which overt TSH deficiency is the most consistent feature. We also show that macroorchidism is not obligatory in males with IDS. Mutations of IGSF1 should therefore be considered in males with isolated hypopituitarism that includes TSH deficiency.
OBJECTIVES:IGSF1 deficiency syndrome (IDS) is a recently described X-linked congenital central hypothyroidism disorder characterized by loss-of-function mutations in the immunoglobulin superfamily member 1 (IGSF1) gene. The phenotypic spectrum and intrafamilial variability associated with IDS remain unclear due to a paucity of large, well-characterized pedigrees. Here, we present phenotypic analysis and molecular characterization of a five-generation pedigree with IGSF1 deficiency containing 10 affected males. PATIENTS AND METHODS: Pituitary function was assessed in all available family members (n = 8 affected males and n = 5 carrier females). Molecular characterization of the family was performed by Sanger sequencing of PCR products amplified from the IGSF1 locus and by array comparative genomic hybridization. RESULTS: A 42-kb IGSF1 deletion spanning the entire coding sequence was identified in all affected males. TSH deficiency, although subclinical in one case, was identified in all affected males (n = 8). PRL and GH deficiency were also present in 5 of 6 and 4 of 8 affected males, respectively. In contrast to previous reports, macroorchidism was not detected in any of the four affected males who were examined for this feature. Only 1 of 5 carrier females had pituitary dysfunction (TSH and GH deficiency). CONCLUSION: Individuals with identical IGSF1 deletions can exhibit variable pituitary hormone deficiencies, of which overt TSH deficiency is the most consistent feature. We also show that macroorchidism is not obligatory in males with IDS. Mutations of IGSF1 should therefore be considered in males with isolated hypopituitarism that includes TSH deficiency.
Authors: Marc-Olivier Turgeon; Tanya L Silander; Denica Doycheva; Xiao-Hui Liao; Marc Rigden; Luisina Ongaro; Xiang Zhou; Sjoerd D Joustra; Jan M Wit; Mike G Wade; Heike Heuer; Samuel Refetoff; Daniel J Bernard Journal: Endocrinology Date: 2017-04-01 Impact factor: 4.736
Authors: Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper Journal: Endocr Rev Date: 2016-11-09 Impact factor: 19.871
Authors: Marta García; Raquel Barrio; Montserrat García-Lavandeira; Angela R Garcia-Rendueles; Adela Escudero; Esther Díaz-Rodríguez; Darya Gorbenko Del Blanco; Ana Fernández; Yolanda B de Rijke; Elena Vallespín; Julián Nevado; Pablo Lapunzina; Vilborg Matre; Patricia M Hinkle; Anita C S Hokken-Koelega; María P de Miguel; José Manuel Cameselle-Teijeiro; Manuel Nistal; Clara V Alvarez; José C Moreno Journal: Sci Rep Date: 2017-03-06 Impact factor: 4.379
Authors: Edna F Roche; Anne McGowan; Olympia Koulouri; Marc-Olivier Turgeon; Adeline K Nicholas; Emmeline Heffernan; Ranna El-Khairi; Noina Abid; Greta Lyons; David Halsall; Marco Bonomi; Luca Persani; Mehul T Dattani; Mark Gurnell; Daniel J Bernard; Nadia Schoenmakers Journal: Clin Endocrinol (Oxf) Date: 2018-10-01 Impact factor: 3.478